KDDW 2019 Program at a Glance(KASL) |
Date: Nov. 28 (Thu) Place: convention Hall A+B (4F) |
Time | Subject | Detail |
09:00-10:30 | Symposium 01 | Noticeable research of liver disease in year 2019 |
Chair(s): Jung-Hwan Yoon, Kwan Soo Byun |
09:00-09:22 | Viral Hepatitis | Hyung Joon Yim |
09:22-09:44 | Alchol-related and non-alcoholic fatty diseases | Ying Kyun Cho |
09:44-10:06 | Liver cirrhosis and complications | Moon Young Kim |
10:06-10:28 | Hepatocellular carcinoma | Ju Hyun Shim |
10:30-11:00 | Coffee Break |
11:00-12:30 | Chung Yong Kim Memorial Lecture | Presidential Lecture - Chung Yong Kim Memorial Lecture |
Chair(s): Kwan Sik Lee |
11:00-11:30 | Alcoholic Liver Disease-Past, Present, and Future | Dong Joon Kim |
General Meeting | 11:30-12:30 | General Meeting | KASL |
12:30-13:30 | Luncheon Symposium |
13:30-14:00 | Break |
14:00-15:30 | Symposium 03 | Modulation of gut-liver axis in liver diseases: How far have we come? |
Chair(s): Jin Mo Yang , Kwang Cheol Koh |
14:00-14:20 | Gut-liver axis to regulate hepatic steatosis | Hail Kim |
14:20-14:40 | Dysbiosis in patients with liver cirrhosis | Do Seon Song |
14:40-15:00 | Gut microbiome and hepatocarcinogenesis | Su Jong Yu |
15:00-15:20 | Fecal microbiota transplantation in chronic liver diseases | Ki Tae Suk |
15:20-15:30 | Discussion | |
15:30-16:00 | Coffee Break |
16:00-17:30 | Symposium 04 | Recent updates in management of liver diseases |
Chair(s): Kwang-Hyub Han, Han Chu Lee |
16:00-16:20 | Clinical development of new HBV therapies | Sang Hoon Ahn |
16:20-16:40 | Management of diabetes and dyslipidemia in patients with NASH | Seung-Hyun Ko |
16:40-17:00 | Management of autoimmune hepatitis: experiences in real clinical practice | Kang Mo Kim |
17:00-17:20 | Local ablation therapy of hepatocellular carcinoma | Seung Kak Shin |
17:20-17:30 | Discussion | |